Insider Transactions in Q3 2022 at Pliant Therapeutics, Inc. (PLRX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2022
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
2,000,000
-34.25%
|
-
|
|
Sep 12
2022
|
Bernard Coulie President and CEO |
SELL
Open market or private sale
|
Direct |
12,502
-17.42%
|
$275,044
$22.54 P/Share
|
|
Sep 12
2022
|
Bernard Coulie President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,502
+14.83%
|
$25,004
$2.08 P/Share
|
|
Jul 12
2022
|
Bernard Coulie President and CEO |
SELL
Open market or private sale
|
Direct |
12,498
-17.41%
|
$274,956
$22.5 P/Share
|
|
Jul 12
2022
|
Bernard Coulie President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,498
+14.83%
|
$24,996
$2.08 P/Share
|
|
Jul 11
2022
|
Eric Lefebvre Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,000
-2.12%
|
$60,000
$20.0 P/Share
|
|
Jul 11
2022
|
Bernard Coulie President and CEO |
SELL
Open market or private sale
|
Direct |
15,000
-20.2%
|
$330,000
$22.5 P/Share
|
|
Jul 11
2022
|
Bernard Coulie President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+16.8%
|
$30,000
$2.08 P/Share
|